NIM
JANX icon

NEOS Investment Management’s Janux Therapeutics JANX Stock Holding History

NEOS Investment Management’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,647
Closed -$520K – 618
2025
Q4 		$520K Sell
37,647
-2,704
-7% -$63.6K ﹤0.01% 603
2025
Q3 		$986K Sell
40,351
-9,714
-19% -$237K 0.01% 523
2025
Q2 		$1.16M Buy
50,065
+4,128
+9% +$109K 0.01% 456
2025
Q1 		$1.24M Buy
45,937
+40,714
+780% +$1.53M 0.02% 408
2024
Q4 		$280K Sell
5,223
-8,053
-61% -$426K 0.01% 558
2024
Q3 		$603K Buy
13,276
+3,553
+37% +$155K 0.02% 467
2024
Q2 		$407K Buy
+9,723
New +$457K 0.02% 486

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

NEOS Investment Management's JANX Position: Q1 2026 in Review

NEOS Investment Management sold out of Janux Therapeutics (JANX) in Q1 2026, closing a stake of 37,647 shares — an estimated $520K sold.

NEOS Investment Management first reported a position in JANX in Q2 2024 and held it in 7 quarters. The position peaked at $1.24M in Q1 2025. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

  • NEOS Investment Management reported no remaining Janux Therapeutics position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 37,647 Janux Therapeutics shares in Q1 2026, an estimated $520K.
  • NEOS Investment Management first reported a position in Janux Therapeutics in Q2 2024 and held it in 7 quarters.
  • NEOS Investment Management's Janux Therapeutics position peaked at $1.24M in Q1 2025.
  • 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.